Cited by — Structural engineering of dual-targeting antisense oligonucleotides enhances exon 44 skipping for treating Duchenne muscular dystrophy | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Structural engineering of dual-targeting antisense oligonucleotides enhances exon 44 skipping for treating Duchenne muscular dystrophy.
No admitted local citation edges point to this work yet.
